Lucilla Parnetti
Clinica Neurologica
Ospedale S. Maria della Misericordia
Università degli studi di Perugia
Perugia
Italy
Name/email consistency: high
- Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease. Parnetti, L., Chiasserini, D., Andreasson, U., Ohlson, M., Hüls, C., Zetterberg, H., Minthon, L., Wallin, A.K., Andreasen, N., Talesa, V.N., Blennow, K. Acta Neurol. Scand. (2011)
- Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias. Parnetti, L., Chiasserini, D., Bellomo, G., Giannandrea, D., De Carlo, C., Qureshi, M.M., Ardah, M.T., Varghese, S., Bonanni, L., Borroni, B., Tambasco, N., Eusebi, P., Rossi, A., Onofrj, M., Padovani, A., Calabresi, P., El-Agnaf, O. Mov. Disord. (2011)
- CSF levels of heart fatty acid binding protein are altered during early phases of Alzheimer's disease. Chiasserini, D., Parnetti, L., Andreasson, U., Zetterberg, H., Giannandrea, D., Calabresi, P., Blennow, K. J. Alzheimers Dis. (2010)
- Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies. Parnetti, L., Balducci, C., Pierguidi, L., De Carlo, C., Peducci, M., D'Amore, C., Padiglioni, C., Mastrocola, S., Persichetti, E., Paciotti, S., Bellomo, G., Tambasco, N., Rossi, A., Beccari, T., Calabresi, P. Neurobiol. Dis. (2009)
- Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies. Parnetti, L., Tiraboschi, P., Lanari, A., Peducci, M., Padiglioni, C., D'Amore, C., Pierguidi, L., Tambasco, N., Rossi, A., Calabresi, P. Biol. Psychiatry (2008)
- Diagnosing prodromal Alzheimer's disease: role of CSF biochemical markers. Parnetti, L., Lanari, A., Silvestrelli, G., Saggese, E., Reboldi, P. Mech. Ageing Dev. (2006)
- Stroke prevention and statin treatment. Parnetti, L., Caso, V., Lanari, A., Saggese, E., Sebastianelli, M., Tayebati, S.K., Amenta, F. Clin. Exp. Hypertens. (2006)
- Efficacy of thrombolytic (rt-PA) therapy in old stroke patients: the Perugia Stroke Unit experience. Parnetti, L., Silvestrelli, G., Lanari, A., Tambasco, N., Capocchi, G., Agnelli, G. Clin. Exp. Hypertens. (2006)
- Mild hyperhomocysteinemia is a risk-factor in all etiological subtypes of stroke. Parnetti, L., Caso, V., Santucci, A., Corea, F., Lanari, A., Floridi, A., Conte, C., Bottiglieri, T. Neurol. Sci. (2004)
- Hyperhomocyst(e)inemia: a risk factor for cerebrovascular disease. Parnetti, L., Caso, V., Amici, S., Lanari, A., Gallai, V., Bottiglieri, T. Clin. Exp. Hypertens. (2002)
- Pharmacological treatment of non-cognitive disturbances in dementia disorders. Parnetti, L., Amici, S., Lanari, A., Gallai, V. Mech. Ageing Dev. (2001)
- Cerebrospinal fluid pyruvate levels in Alzheimer's disease and vascular dementia. Parnetti, L., Reboldi, G.P., Gallai, V. Neurology (2000)
- Therapeutic options in dementia. Parnetti, L. J. Neurol. (2000)
- Atrial fibrillation and stroke. Parnetti, L., Gallai, V. Cerebrovasc. Dis. (2000)
- Pathophysiology of vascular dementia and white matter changes. Parnetti, L. Rev. Neurol. (Paris) (1999)
- Cognitive enhancement therapy for Alzheimer's disease. The way forward. Parnetti, L., Senin, U., Mecocci, P. Drugs (1997)
- Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging. Parnetti, L., Tarducci, R., Presciutti, O., Lowenthal, D.T., Pippi, M., Palumbo, B., Gobbi, G., Pelliccioli, G.P., Senin, U. Mech. Ageing Dev. (1997)
- Vascular dementia Italian sulodexide study (VA.D.I.S.S.). Clinical and biological results. Parnetti, L., Mari, D., Abate, G., Balestreri, R., Cucinotta, D., Coppola, R., Cherubini, A., Ferrari, P., Senin, U. Thromb. Res. (1997)
- Diagnosing Alzheimer's disease in very elderly patients. Relevance of some functional and psychobehavioral aspects assessed by the Gottfries-Bråne-Steen Rating Scale for Dementia. Study Group on Brain Aging, Italian Society of Gerontology and Geriatrics. Parnetti, L., Brooks, J.O., Pippi, M., Caputo, N., Chionne, F., Senin, U. Gerontology (1997)